Shareholders Equity (Quarterly) Chart

View Shareholders Equity (Quarterly) for AGL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Shareholders Equity (Quarterly) Chart
Start Trial

Historical Shareholders Equity (Quarterly) Data

View and export this data back to 2020. Start Trial.
Date Value
June 30, 2026 227.53M
March 31, 2026 181.43M
December 31, 2025 126.73M
September 30, 2025 306.08M
June 30, 2025 408.93M
March 31, 2025 500.25M
December 31, 2024 470.95M
September 30, 2024 574.87M
June 30, 2024 676.64M
March 31, 2024 689.27M
December 31, 2023 661.84M
September 30, 2023 872.37M
Date Value
June 30, 2023 880.17M
March 31, 2023 1.083B
December 31, 2022 1.041B
September 30, 2022 1.086B
June 30, 2022 1.104B
March 31, 2022 1.112B
December 31, 2021 1.092B
September 30, 2021 1.128B
June 30, 2021 1.150B
March 31, 2021 -298.17M
December 31, 2020 -284.73M

Shareholders' Equity Definition

Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.

Read full definition.

Shareholders Equity (Quarterly) Range, Past 5 Years

View Shareholders Equity (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shareholders Equity (Quarterly) Benchmarks

View Shareholders Equity (Quarterly) Benchmarks
Start Trial
Astrana Health, Inc. 830.22M
Starling Oncology, Inc. -24.91M
Nakamoto, Inc. 236.41M
American Oncology Network, Inc. --
Tenet Healthcare Corp. 4.658B

Shareholders Equity (Quarterly) Related Metrics